Bright prospect expected for drug makers in third quarter

Optimism is growing over the third quarter outlook for Korea’ leading pharmaceutical firms as they are pushing up with co-marketing strategies with multinational firms, according to a report by Shinhan Finance & Investment Securities.

The report showed that the combined revenue of the large eight companies is forecast to post 1.31 trillion won in the third quarter of this year, up 4.3 percen...